UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of November, 2025
Commission File Number 001-40772
Cellebrite DI Ltd.
(Translation
of registrant’s name into English)
94 Shlomo Shmelzer Road
Petah Tikva 4970602, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On November 12, 2025,
Cellebrite DI Ltd. (the “Registrant” or “Cellebrite”) issued a press release titled “Cellebrite Announces
Third-Quarter 2025 Results.” A copy of this press release is furnished as Exhibit 99.1 herewith.
The GAAP financial statements tables contained in the press release
attached to this report on Form 6-K are incorporated by reference into the Registrant’s registration statements on Form S-8 (File
Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and
March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.
EXHIBIT INDEX
| Exhibit |
|
Description |
| 99.1 |
|
Press release titled “Cellebrite Announces Third-Quarter 2025 Results” (furnished herewith). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Cellebrite DI Ltd. |
| |
|
| Date:
November 12, 2025 |
By: |
/s/ David Barter |
| |
|
David Barter |
| |
|
Chief Financial Officer |
